1-Ethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine, 98%, 1g

3,5-Dibromo-1-fluoro-4-isopropoxybenzene, 98.0%, 5g

ethyl 7-oxo-1H,7H-imidazo[1,2-a]pyridine-3-carboxylate, 97%, 1g

4-[(2,4-Dimethylphenyl)sulfanyl]aniline hydrochloride, 95%, 250mg

3,5-DIMETHYLI-4-ISOXAZOLECARBOXAMIDE, 98.0%, 100g

4-Chloro-N-methyl-2-nitrobenzenesulfonamide, 97%, 100mg

Hexafluoroisopropyl Methyl Ether>98.0%(GC)25g

1-Phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 250mg

4-(chloromethyl)-N-(3-methoxyphenyl)-1,3-thiazol-2-amine hydrochloride, 95.0%, 250mg

Methyl 3-Aminoisonicotinate, 98.0%, 1g

4,4'-Bis(bromomethyl)-2,2'-bipyridine, 95.0%, 250mg

Benzyl 4-amino-4-methylpiperidine-1-carboxylate, 95.0%, 10g

Dialysis membrane Spectra/Por® 1 to 4 Spectra/Por® 1 - MWCO 6000 to 8000, 100 mm, 15 m, 1 Piece(s)